• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管手术中应选择哪种抗生素进行预防?

[Which antibiotics should one choose for prophylaxis in vascular surgery?].

作者信息

Veit R, Melliere D, Etienne G, Becquemin J P, Brunbuisson C, Otterbein G

出版信息

J Chir (Paris). 1986 Nov;123(11):621-5.

PMID:3611218
Abstract

Although the principle and duration of prophylactic antibiotic therapy in prosthetic vascular surgery are fairly widely accepted, the choice of antibiotic is still open to discussion. During two successive periods, identical groups of patients received peri-operative prophylaxis with, during period I (455 cases) oxacillin alone and during period II (537 cases) combined treatment with oxacillin and amikacin. The aim of the study was to evaluate efficacy of the association and to draw general conclusions on choice of antibiotic. The addition of amikacin reduced frequency of infection in elective operations, particularly aorto-ilio-femoral prostheses (0.5% as against 1.24%), but not in operations conducted as emergencies. In addition, frequency of infection due to BGN fell only slightly. Finally, combined therapy with oxacillin-amikacin had 2 disadvantages: impossibility of using these antibiotics for prophylaxis alone as provided for in the protocol, and its high cost. Factors of choice of antibiotic should be: efficacy against germs encountered, which can vary from year to year, rarity of toxic or side effects, good tissue diffusion, the rare need for therapeutic use and a low cost.

摘要

尽管人工血管手术中预防性抗生素治疗的原则和疗程已得到相当广泛的认可,但抗生素的选择仍有待探讨。在两个连续的时间段内,相同组别的患者接受围手术期预防治疗,在第一阶段(455例)仅使用苯唑西林,在第二阶段(537例)使用苯唑西林和阿米卡星联合治疗。本研究的目的是评估联合用药的疗效,并就抗生素的选择得出一般性结论。添加阿米卡星降低了择期手术的感染发生率,尤其是主动脉-髂股人工血管手术(分别为0.5%和1.24%),但在急诊手术中并未降低。此外,由革兰阴性菌引起的感染发生率仅略有下降。最后,苯唑西林-阿米卡星联合治疗有两个缺点:无法按照方案规定单独使用这些抗生素进行预防,且成本高昂。选择抗生素的因素应包括:对每年可能不同的常见病菌有效、毒性或副作用罕见、良好的组织扩散性、极少需要用于治疗用途以及低成本。

相似文献

1
[Which antibiotics should one choose for prophylaxis in vascular surgery?].血管手术中应选择哪种抗生素进行预防?
J Chir (Paris). 1986 Nov;123(11):621-5.
2
[Methods for preparing patients to vascular surgery. Our experience].[患者血管手术术前准备方法。我们的经验]
Minerva Chir. 1989 Apr 30;44(8):1203-5.
3
[Antibiotic treatment for prevention of infectious complications in joint replacement].[抗生素治疗预防关节置换术中的感染并发症]
Acta Chir Orthop Traumatol Cech. 2006 Apr;73(2):108-14.
4
[Antibiotic prophylaxis in surgery. Results of a 4-year personal case series].
Minerva Chir. 1992 Jun 30;47(12):1095-9.
5
[Perioperative preventive use of antibiotics in neurosurgery. Experience with a fixed antibiotic combination of mezlocillin and oxacillin (optocillin)].[神经外科围手术期预防性使用抗生素。美洛西林与苯唑西林(奥普西林)固定抗生素组合的经验]
Neurochirurgia (Stuttg). 1991 Jan;34(1):14-7. doi: 10.1055/s-2008-1052049.
6
[Basic aspects of the preventive use of antibiotics in general surgery].
Zentralbl Chir. 1989;114(24):1533-9.
7
Short-term preventive antibiotics.短期预防性抗生素
Clin Orthop Relat Res. 1986 Apr(205):184-7.
8
[The use of antibiotics in surgical prophylaxis. The characteristics and consequences].
Med Clin (Barc). 1993 Mar 20;100(11):404-6.
9
[Antibiotic prevention and occurrence of wound infections in heart surgery and vascular surgery].[心脏手术和血管手术中抗生素预防与伤口感染的发生情况]
Tidsskr Nor Laegeforen. 1994 Oct 30;114(26):3071-4.
10
Perioperative infection prophylaxis in vascular surgery--a randomized prospective study.
Thorac Cardiovasc Surg. 1983 Aug;31(4):239-42.

引用本文的文献

1
Prevention of infection in peripheral arterial reconstruction of the lower limb.下肢周围动脉重建术中的感染预防
Cochrane Database Syst Rev. 2025 Oct 29;10(10):CD015022. doi: 10.1002/14651858.CD015022.pub2.
2
Prevention of infection in aortic or aortoiliac peripheral arterial reconstruction.主动脉或主-髂动脉周围动脉重建术中的感染预防
Cochrane Database Syst Rev. 2025 Apr 22;4(4):CD015192. doi: 10.1002/14651858.CD015192.pub2.